Cooper Companies (NASDAQ:COO) Price Target Raised to $82.00 at Wells Fargo & Company

Cooper Companies (NASDAQ:COO) had its target price boosted by research analysts at Wells Fargo & Company from $72.00 to $82.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has an “equal weight” rating on the medical device company’s stock. Wells Fargo & Company‘s price target would suggest a potential upside of 0.42% from the company’s current price.

A number of other research analysts also recently commented on COO. The Goldman Sachs Group set a $64.00 target price on Cooper Companies and gave the company a “sell” rating in a research note on Wednesday, October 1st. Weiss Ratings restated a “hold (c-)” rating on shares of Cooper Companies in a report on Monday. Piper Sandler reaffirmed an “overweight” rating and set a $94.00 price objective on shares of Cooper Companies in a research report on Friday. Stifel Nicolaus set a $95.00 target price on shares of Cooper Companies in a research note on Friday. Finally, Needham & Company LLC reissued a “buy” rating and issued a $100.00 target price (up from $94.00) on shares of Cooper Companies in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $90.31.

Cooper Companies Stock Up 6.0%

Shares of COO stock traded up $4.63 during trading on Friday, hitting $81.66. 3,692,179 shares of the company were exchanged, compared to its average volume of 2,413,876. The business’s 50-day simple moving average is $72.01 and its 200 day simple moving average is $71.74. Cooper Companies has a twelve month low of $61.78 and a twelve month high of $101.53. The firm has a market capitalization of $16.24 billion, a price-to-earnings ratio of 40.18, a P/E/G ratio of 1.87 and a beta of 1.05. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, analysts forecast that Cooper Companies will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a share repurchase program on Wednesday, September 17th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.

Insider Buying and Selling

In other news, Director Lawrence Erik Kurzius purchased 2,000 shares of the company’s stock in a transaction dated Monday, September 29th. The shares were bought at an average price of $68.39 per share, with a total value of $136,780.00. Following the completion of the transaction, the director directly owned 5,777 shares in the company, valued at $395,089.03. This trade represents a 52.95% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.98% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of COO. Janney Montgomery Scott LLC grew its position in shares of Cooper Companies by 5.1% in the second quarter. Janney Montgomery Scott LLC now owns 97,394 shares of the medical device company’s stock valued at $6,931,000 after purchasing an additional 4,761 shares during the last quarter. United Services Automobile Association acquired a new position in shares of Cooper Companies during the 1st quarter worth about $414,000. Ruffer LLP bought a new stake in Cooper Companies during the 2nd quarter valued at approximately $17,624,000. Asset Management One Co. Ltd. grew its holdings in Cooper Companies by 3.2% in the 2nd quarter. Asset Management One Co. Ltd. now owns 88,313 shares of the medical device company’s stock valued at $6,284,000 after buying an additional 2,746 shares during the last quarter. Finally, Amica Mutual Insurance Co. acquired a new stake in Cooper Companies in the 2nd quarter valued at approximately $1,060,000. Institutional investors own 24.39% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.